search

Alkermes Plc (ALKS)

OverviewChartFinancialsStatisticsEarningsInsider transactionsETFsNews

Insider transactions

A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.

Transaction date
Executive
Executive Title
Security Type
Acquisition / Disposal
Shares
Share price
Sep 3, 2026GAFFIN, DAVID JOSEPHEVP, CLO, Alkermes, Inc.Ordinary SharesDisposal2,03448.01
Sep 1, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesDisposal9,00046.986
Sep 1, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerEmployee Stock Option (Right to Buy)Disposal5,0000
Sep 1, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesAcquisition5,00024.59
Aug 17, 2026NICHOLS, CHRISTIAN TODDSVP, Chief Commercial OfficerOrdinary SharesDisposal6,91249.185
Aug 17, 2026NICHOLS, CHRISTIAN TODDSVP, Chief Commercial OfficerOrdinary SharesDisposal66449.653
Aug 5, 2026JACKSON, BLAIR CURTISDirector, President & CEO, Alkermes plcEmployee Stock Option (Right to Buy)Acquisition124,3050
Aug 5, 2026JACKSON, BLAIR CURTISDirector, President & CEO, Alkermes plcEmployee Stock Option (Right to Buy)Acquisition93,2290
Aug 3, 2026SNYDERMAN, NANCY LYNN MDDirectorOrdinary SharesAcquisition16,52446.72
Aug 3, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesDisposal9,00048.58
Aug 3, 2026SNYDERMAN, NANCY LYNN MDDirectorNon Qualified Stock Option (Right to Buy)Disposal16,5240
Aug 3, 2026SNYDERMAN, NANCY LYNN MDDirectorOrdinary SharesDisposal44,47250.348
Aug 3, 2026GAFFIN, DAVID JOSEPHEVP, CLO, Alkermes, Inc.Ordinary SharesDisposal2,03448.58
Aug 3, 2026SNYDERMAN, NANCY LYNN MDDirectorNon Qualified Stock Option (Right to Buy)Disposal27,9480
Aug 3, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerEmployee Stock Option (Right to Buy)Disposal4,8960
Aug 3, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerEmployee Stock Option (Right to Buy)Disposal1040
Aug 3, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesAcquisition10419.34
Aug 3, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesAcquisition4,89624.59
Aug 3, 2026SNYDERMAN, NANCY LYNN MDDirectorOrdinary SharesAcquisition27,94846.72
Jul 6, 2026GAFFIN, DAVID JOSEPHEVP, CLO, Alkermes, Inc.Ordinary SharesDisposal2,03454.03
Jul 1, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesAcquisition5,00019.34
Jul 1, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesDisposal70052.131
Jul 1, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerEmployee Stock Option (Right to Buy)Disposal5,0000
Jul 1, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesDisposal8,30051.461
Jun 12, 2026WRIGHT, CHRISTOPHER IDirectorOrdinary SharesDisposal2,00045.1
Jun 4, 2026GAFFIN, DAVID JOSEPHEVP, CLO, Alkermes, Inc.Ordinary SharesDisposal2,03443.05
Jun 1, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerEmployee Stock Option (Right to Buy)Disposal5,0000
Jun 1, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesAcquisition5,00019.34
Jun 1, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesDisposal9,00041.672
May 29, 2026PARISI, SAMUEL JOSEPHVP, Finance (Interim PAO)Ordinary SharesDisposal16,21742.363
May 29, 2026PARISI, SAMUEL JOSEPHVP, Finance (Interim PAO)Ordinary SharesAcquisition12,82519.34
May 29, 2026PARISI, SAMUEL JOSEPHVP, Finance (Interim PAO)Employee Stock Option (Right to Buy)Disposal3,3920
May 29, 2026PARISI, SAMUEL JOSEPHVP, Finance (Interim PAO)Employee Stock Option (Right to Buy)Disposal12,8250
May 29, 2026PARISI, SAMUEL JOSEPHVP, Finance (Interim PAO)Ordinary SharesAcquisition3,39220.03
May 21, 2026LURKER, NANCYDirectorOrdinary SharesDisposal1,47536.95
May 21, 2026SNYDERMAN, NANCY LYNN MDDirectorRestricted Stock Unit AwardDisposal6,142
May 21, 2026COOKE, SHANEDirectorRestricted Stock Unit AwardDisposal6,142
May 21, 2026COOKE, SHANEDirectorRestricted Stock Unit AwardDisposal6,142
May 21, 2026SNYDERMAN, NANCY LYNN MDDirectorOrdinary SharesAcquisition6,142
May 21, 2026MCKEON, BRIAN PDirectorRestricted Stock Unit AwardDisposal6,142
May 21, 2026LAURENCIN, CATO TDirectorOrdinary SharesDisposal1,47536.95
May 21, 2026COOKE, SHANEDirectorOrdinary SharesAcquisition6,142
May 21, 2026COOKE, SHANEDirectorOrdinary SharesAcquisition6,142
May 21, 2026WRIGHT, CHRISTOPHER IDirectorRestricted Stock Unit AwardDisposal6,142
May 21, 2026MCKEON, BRIAN PDirectorOrdinary SharesAcquisition6,142
May 21, 2026WILSON, FRANK ANDERSDirectorOrdinary SharesDisposal1,47536.95
May 21, 2026GAYNOR, RICHARDDirectorOrdinary SharesAcquisition6,142
May 21, 2026GAYNOR, RICHARDDirectorOrdinary SharesAcquisition6,142
May 21, 2026GAYNOR, RICHARDDirectorRestricted Stock Unit AwardDisposal6,142
May 21, 2026GAYNOR, RICHARDDirectorRestricted Stock Unit AwardDisposal6,142
May 21, 2026WRIGHT, CHRISTOPHER IDirectorOrdinary SharesAcquisition6,142
May 21, 2026LAURENCIN, CATO TDirectorRestricted Stock Unit AwardDisposal6,142
May 21, 2026WILSON, FRANK ANDERSDirectorRestricted Stock Unit AwardDisposal6,142
May 21, 2026LAURENCIN, CATO TDirectorOrdinary SharesAcquisition6,142
May 21, 2026LURKER, NANCYDirectorRestricted Stock Unit AwardDisposal6,142
May 21, 2026MCKEON, BRIAN PDirectorOrdinary SharesDisposal1,47536.95
May 21, 2026WILSON, FRANK ANDERSDirectorOrdinary SharesAcquisition6,142
May 21, 2026GAYNOR, RICHARDDirectorOrdinary SharesDisposal1,47536.95
May 21, 2026GAYNOR, RICHARDDirectorOrdinary SharesDisposal1,47536.95
May 21, 2026LURKER, NANCYDirectorOrdinary SharesAcquisition6,142
May 21, 2026WRIGHT, CHRISTOPHER IDirectorOrdinary SharesDisposal1,47536.95
May 21, 2026COOKE, SHANEDirectorOrdinary SharesDisposal3,20736.95
May 21, 2026COOKE, SHANEDirectorOrdinary SharesDisposal3,20736.95
May 21, 2026SNYDERMAN, NANCY LYNN MDDirectorOrdinary SharesDisposal1,47536.95
May 20, 2026MCKEON, BRIAN PDirectorNon Qualified Stock Option (Right to Buy)Acquisition11,5380
May 20, 2026WRIGHT, CHRISTOPHER IDirectorNon Qualified Stock Option (Right to Buy)Acquisition11,5380
May 20, 2026LAURENCIN, CATO TDirectorNon Qualified Stock Option (Right to Buy)Acquisition11,5380
May 20, 2026WRIGHT, CHRISTOPHER IDirectorRestricted Stock Unit AwardAcquisition5,4090
May 20, 2026SNYDERMAN, NANCY LYNN MDDirectorRestricted Stock Unit AwardAcquisition5,4090
May 20, 2026COOKE, SHANEDirectorRestricted Stock Unit AwardAcquisition5,4090
May 20, 2026COOKE, SHANEDirectorRestricted Stock Unit AwardAcquisition5,4090
May 20, 2026SNYDERMAN, NANCY LYNN MDDirectorNon Qualified Stock Option (Right to Buy)Acquisition11,5380
May 20, 2026LURKER, NANCYDirectorNon Qualified Stock Option (Right to Buy)Acquisition11,5380
May 20, 2026GAYNOR, RICHARDDirectorRestricted Stock Unit AwardAcquisition5,4090
May 20, 2026GAYNOR, RICHARDDirectorRestricted Stock Unit AwardAcquisition5,4090
May 20, 2026COOKE, SHANEDirectorNon Qualified Stock Option (Right to Buy)Acquisition11,5380
May 20, 2026COOKE, SHANEDirectorNon Qualified Stock Option (Right to Buy)Acquisition11,5380
May 20, 2026MCKEON, BRIAN PDirectorRestricted Stock Unit AwardAcquisition5,4090
May 20, 2026WILSON, FRANK ANDERSDirectorRestricted Stock Unit AwardAcquisition5,4090
May 20, 2026LURKER, NANCYDirectorRestricted Stock Unit AwardAcquisition5,4090
May 20, 2026WILSON, FRANK ANDERSDirectorNon Qualified Stock Option (Right to Buy)Acquisition11,5380
May 20, 2026GAYNOR, RICHARDDirectorNon Qualified Stock Option (Right to Buy)Acquisition11,5380
May 20, 2026LAURENCIN, CATO TDirectorRestricted Stock Unit AwardAcquisition5,4090
May 4, 2026GAFFIN, DAVID JOSEPHEVP, CLO, Alkermes, Inc.Ordinary SharesDisposal2,03433.2
May 1, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesAcquisition5,00019.34
May 1, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerEmployee Stock Option (Right to Buy)Disposal5,0000
May 1, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesDisposal9,00033.396
Apr 11, 2026LURKER, NANCYDirectorOrdinary SharesAcquisition3,751
Apr 11, 2026LURKER, NANCYDirectorRestricted Stock Unit AwardDisposal3,751
Apr 11, 2026LURKER, NANCYDirectorOrdinary SharesDisposal90133.36
Apr 6, 2026GAFFIN, DAVID JOSEPHEVP, CLO, Alkermes, Inc.Ordinary SharesDisposal2,03434.57
Apr 1, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesDisposal9,00035.512
Apr 1, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerEmployee Stock Option (Right to Buy)Disposal5,0000
Apr 1, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesAcquisition5,00019.34
Mar 3, 2026GAFFIN, DAVID JOSEPHEVP, CLO, Alkermes, Inc.Ordinary SharesDisposal2,03429.76
Mar 2, 2026GAFFIN, DAVID JOSEPHEVP, CLO, Alkermes, Inc.Employee Stock Option (Right to Buy)Acquisition78,2920
Mar 2, 2026REED, JOSHUASVP, Chief Financial OfficerRestricted Stock Unit AwardAcquisition30,8540
Mar 2, 2026PARISI, SAMUEL JOSEPHVP, Finance (Interim PAO)Restricted Stock Unit AwardAcquisition14,1760
Mar 2, 2026GAFFIN, DAVID JOSEPHEVP, CLO, Alkermes, Inc.Restricted Stock Unit AwardAcquisition36,3640
Mar 2, 2026NICHOLS, CHRISTIAN TODDSVP, Chief Commercial OfficerEmployee Stock Option (Right to Buy)Acquisition66,4300
Mar 2, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesAcquisition5,00019.34
Mar 2, 2026PARISI, SAMUEL JOSEPHVP, Finance (Interim PAO)Ordinary SharesDisposal6,89029.29
Mar 2, 2026NICHOLS, CHRISTIAN TODDSVP, Chief Commercial OfficerRestricted Stock Unit AwardAcquisition30,8540
Mar 2, 2026REED, JOSHUASVP, Chief Financial OfficerEmployee Stock Option (Right to Buy)Acquisition66,4300
Mar 2, 2026JACKSON, BLAIR CURTISEVP, Chief Operating OfficerEmployee Stock Option (Right to Buy)Acquisition94,9000
Mar 2, 2026PARISI, SAMUEL JOSEPHVP, Finance (Interim PAO)Employee Stock Option (Right to Buy)Acquisition15,0330
Mar 2, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesDisposal9,00029.721
Mar 2, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerEmployee Stock Option (Right to Buy)Acquisition83,0370
Mar 2, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerEmployee Stock Option (Right to Buy)Disposal5,0000
Mar 2, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerRestricted Stock Unit AwardAcquisition38,5680
Mar 2, 2026GAFFIN, DAVID JOSEPHEVP, CLO, Alkermes, Inc.Ordinary SharesDisposal2,03429.29
Mar 2, 2026POPS, RICHARD FDirector, Director and CEO, Alkermes plcRestricted Stock Unit AwardAcquisition88,8430
Mar 2, 2026JACKSON, BLAIR CURTISEVP, Chief Operating OfficerRestricted Stock Unit AwardAcquisition44,0780
Mar 2, 2026NICHOLS, CHRISTIAN TODDSVP, Chief Commercial OfficerOrdinary SharesDisposal6,00030
Feb 26, 2026GAFFIN, DAVID JOSEPHEVP, CLO, Alkermes, Inc.Restricted Stock Unit AwardDisposal6,866
Feb 26, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerRestricted Stock Unit AwardDisposal6,866
Feb 26, 2026JACKSON, BLAIR CURTISEVP, Chief Operating OfficerOrdinary SharesDisposal3,69530.73
Feb 26, 2026PARISI, SAMUEL JOSEPHVP, Finance (Interim PAO)Ordinary SharesAcquisition2,747
Feb 26, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesAcquisition6,866
Feb 26, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesDisposal3,04930.73
Feb 26, 2026NICHOLS, CHRISTIAN TODDSVP, Chief Commercial OfficerRestricted Stock Unit AwardDisposal5,410
Feb 26, 2026JACKSON, BLAIR CURTISEVP, Chief Operating OfficerOrdinary SharesAcquisition8,322
Feb 26, 2026PARISI, SAMUEL JOSEPHVP, Finance (Interim PAO)Restricted Stock Unit AwardDisposal2,747
Feb 26, 2026GAFFIN, DAVID JOSEPHEVP, CLO, Alkermes, Inc.Ordinary SharesAcquisition6,866
Feb 26, 2026GAFFIN, DAVID JOSEPHEVP, CLO, Alkermes, Inc.Ordinary SharesDisposal3,04930.73
Feb 26, 2026JACKSON, BLAIR CURTISEVP, Chief Operating OfficerRestricted Stock Unit AwardDisposal8,322
Feb 26, 2026PARISI, SAMUEL JOSEPHVP, Finance (Interim PAO)Ordinary SharesDisposal80830.73
Feb 26, 2026NICHOLS, CHRISTIAN TODDSVP, Chief Commercial OfficerOrdinary SharesDisposal2,40330.73
Feb 26, 2026NICHOLS, CHRISTIAN TODDSVP, Chief Commercial OfficerOrdinary SharesAcquisition5,410
Feb 23, 2026NICHOLS, CHRISTIAN TODDSVP, Chief Commercial OfficerOrdinary SharesDisposal2,84532.19
Feb 23, 2026GAFFIN, DAVID JOSEPHEVP, CLO, Alkermes, Inc.Ordinary SharesDisposal3,41432.19
Feb 23, 2026JACKSON, BLAIR CURTISEVP, Chief Operating OfficerOrdinary SharesDisposal3,88032.19
Feb 23, 2026PARISI, SAMUEL JOSEPHVP, Finance (Interim PAO)Ordinary SharesAcquisition2,283
Feb 23, 2026JACKSON, BLAIR CURTISEVP, Chief Operating OfficerRestricted Stock Unit AwardDisposal8,738
Feb 23, 2026NICHOLS, CHRISTIAN TODDSVP, Chief Commercial OfficerRestricted Stock Unit AwardDisposal6,407
Feb 23, 2026PARISI, SAMUEL JOSEPHVP, Finance (Interim PAO)Ordinary SharesDisposal67232.19
Feb 23, 2026GAFFIN, DAVID JOSEPHEVP, CLO, Alkermes, Inc.Ordinary SharesAcquisition7,689
Feb 23, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesDisposal3,41432.19
Feb 23, 2026JACKSON, BLAIR CURTISEVP, Chief Operating OfficerOrdinary SharesAcquisition8,738
Feb 23, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesAcquisition7,689
Feb 23, 2026PARISI, SAMUEL JOSEPHVP, Finance (Interim PAO)Restricted Stock Unit AwardDisposal2,283
Feb 23, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerRestricted Stock Unit AwardDisposal7,689
Feb 23, 2026GAFFIN, DAVID JOSEPHEVP, CLO, Alkermes, Inc.Restricted Stock Unit AwardDisposal7,689
Feb 23, 2026NICHOLS, CHRISTIAN TODDSVP, Chief Commercial OfficerOrdinary SharesAcquisition6,407
Feb 19, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerRestricted Stock Unit AwardDisposal7,673
Feb 19, 2026JACKSON, BLAIR CURTISEVP, Chief Operating OfficerOrdinary SharesDisposal4,13032
Feb 19, 2026PARISI, SAMUEL JOSEPHVP, Finance (Interim PAO)Restricted Stock Unit AwardDisposal2,991
Feb 19, 2026JACKSON, BLAIR CURTISEVP, Chief Operating OfficerOrdinary SharesAcquisition9,300
Feb 19, 2026NICHOLS, CHRISTIAN TODDSVP, Chief Commercial OfficerOrdinary SharesAcquisition6,045
Feb 19, 2026NICHOLS, CHRISTIAN TODDSVP, Chief Commercial OfficerRestricted Stock Unit AwardDisposal6,045
Feb 19, 2026PARISI, SAMUEL JOSEPHVP, Finance (Interim PAO)Ordinary SharesDisposal97932
Feb 19, 2026GAFFIN, DAVID JOSEPHEVP, CLO, Alkermes, Inc.Ordinary SharesDisposal3,40732
Feb 19, 2026JACKSON, BLAIR CURTISEVP, Chief Operating OfficerRestricted Stock Unit AwardDisposal9,300
Feb 19, 2026PARISI, SAMUEL JOSEPHVP, Finance (Interim PAO)Ordinary SharesAcquisition2,991
Feb 19, 2026GAFFIN, DAVID JOSEPHEVP, CLO, Alkermes, Inc.Restricted Stock Unit AwardDisposal7,673
Feb 19, 2026NICHOLS, CHRISTIAN TODDSVP, Chief Commercial OfficerOrdinary SharesDisposal2,27732
Feb 19, 2026GAFFIN, DAVID JOSEPHEVP, CLO, Alkermes, Inc.Ordinary SharesAcquisition7,673
Feb 19, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesAcquisition7,673
Feb 19, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesDisposal3,40732
Feb 18, 2026JACKSON, BLAIR CURTISEVP, Chief Operating OfficerRestricted Stock Unit AwardDisposal8,897
Feb 18, 2026GAFFIN, DAVID JOSEPHEVP, CLO, Alkermes, Inc.Ordinary SharesDisposal2,12632.02
Feb 18, 2026JACKSON, BLAIR CURTISEVP, Chief Operating OfficerOrdinary SharesAcquisition8,897
Feb 18, 2026NICHOLS, CHRISTIAN TODDSVP, Chief Commercial OfficerOrdinary SharesAcquisition6,355
Feb 18, 2026NICHOLS, CHRISTIAN TODDSVP, Chief Commercial OfficerOrdinary SharesDisposal1,86932.02
Feb 18, 2026NICHOLS, CHRISTIAN TODDSVP, Chief Commercial OfficerRestricted Stock Unit AwardDisposal6,355
Feb 18, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesDisposal3,50432.02
Feb 18, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesAcquisition8,897
Feb 18, 2026PARISI, SAMUEL JOSEPHVP, Finance (Interim PAO)Ordinary SharesDisposal70632.02
Feb 18, 2026PARISI, SAMUEL JOSEPHVP, Finance (Interim PAO)Restricted Stock Unit AwardDisposal2,034
Feb 18, 2026GAFFIN, DAVID JOSEPHEVP, CLO, Alkermes, Inc.Restricted Stock Unit AwardDisposal6,355
Feb 18, 2026GAFFIN, DAVID JOSEPHEVP, CLO, Alkermes, Inc.Ordinary SharesAcquisition6,355
Feb 18, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerRestricted Stock Unit AwardDisposal8,897
Feb 18, 2026JACKSON, BLAIR CURTISEVP, Chief Operating OfficerOrdinary SharesDisposal3,79632.02
Feb 18, 2026PARISI, SAMUEL JOSEPHVP, Finance (Interim PAO)Ordinary SharesAcquisition2,034
Feb 5, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesDisposal7,45433.55
Feb 5, 2026NICHOLS, CHRISTIAN TODDSVP, Chief Commercial OfficerOrdinary SharesAcquisition21,127
Feb 5, 2026JACKSON, BLAIR CURTISEVP, Chief Operating OfficerOrdinary SharesDisposal8,62633.55
Feb 5, 2026JACKSON, BLAIR CURTISEVP, Chief Operating OfficerOrdinary SharesAcquisition28,810
Feb 5, 2026NICHOLS, CHRISTIAN TODDSVP, Chief Commercial OfficerOrdinary SharesDisposal6,38933.55
Feb 5, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesAcquisition25,352
Feb 5, 2026GAFFIN, DAVID JOSEPHEVP, CLO, Alkermes, Inc.Ordinary SharesAcquisition25,352
Feb 5, 2026POPS, RICHARD FDirector, Director and CEO, Alkermes plcOrdinary SharesAcquisition149,580
Feb 5, 2026GAFFIN, DAVID JOSEPHEVP, CLO, Alkermes, Inc.Ordinary SharesDisposal7,61933.55
Feb 5, 2026POPS, RICHARD FDirector, Director and CEO, Alkermes plcOrdinary SharesDisposal62,23033.55
Feb 2, 2026COOKE, SHANEDirectorOrdinary SharesAcquisition61,20031.64
Feb 2, 2026COOKE, SHANEDirectorOrdinary SharesDisposal29,08734.338
Feb 2, 2026COOKE, SHANEDirectorEmployee Stock Option (Right to Buy)Disposal61,2000
Feb 2, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesDisposal4,00033.54
Feb 2, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesAcquisition5,00019.34
Feb 2, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesDisposal5,00034.245
Feb 2, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerEmployee Stock Option (Right to Buy)Disposal5,0000
Feb 2, 2026COOKE, SHANEDirectorOrdinary SharesDisposal32,11334.78
Jan 8, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerEmployee Stock Option (Right to Buy)Disposal5,0000
Jan 8, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesDisposal5,00030.001
Jan 8, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesAcquisition5,00019.34
Jan 2, 2026HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesDisposal4,00028
Dec 3, 2025HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerEmployee Stock Option (Right to Buy)Disposal3,7480
Dec 3, 2025HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesDisposal3,74830.002
Dec 3, 2025HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesAcquisition3,74819.34
Dec 1, 2025HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesDisposal4,00029.3
Nov 3, 2025HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerEmployee Stock Option (Right to Buy)Disposal5,0000
Nov 3, 2025HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesAcquisition5,00019.34
Nov 3, 2025HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesDisposal9,00030.382
Oct 15, 2025HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesAcquisition5,00019.34
Oct 15, 2025HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerEmployee Stock Option (Right to Buy)Disposal5,0000
Oct 15, 2025HOPKINSON, CRAIG C.EVP R&D, Chief Medical OfficerOrdinary SharesDisposal9,00031.531
Oct 8, 2025REED, JOSHUASVP, Chief Financial OfficerRestricted Stock Unit AwardAcquisition36,6560
Oct 8, 2025REED, JOSHUASVP, Chief Financial OfficerEmployee Stock Option (Right to Buy)Acquisition158,7430